{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/alopecia-androgenetic-male/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"84f86e20-aa91-5e2b-b0b6-bb3cfbf655d6","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field c58ae7cb-ba33-4c47-a173-07e96851d3d3 --><h2>What are the risk factors?</h2><!-- end field c58ae7cb-ba33-4c47-a173-07e96851d3d3 -->","summary":"","htmlStringContent":"<!-- begin item ddc64c67-878a-4009-a6de-d614d05525b3 --><!-- begin field 8d3c4884-0dbc-4854-9ec3-27847ddba5d9 --><ul><li><strong>Family history is the strongest risk factor </strong><strong>for developing androgenetic alopecia in men.</strong><ul><li>Inheritance is polygenic with input from either or both parents.</li><li>The risk is lower in men with a non-balding father and high in those with a balding father.</li></ul></li><li>It is unclear whether there is an association between the development of benign prostatic hyperplasia (BPH) and androgenetic alopecia, as the available evidence provides conflicting results [<a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Severi et al, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Arias-Santiago et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Dastgheib et al, 2015</a>].</li><li><div>Although there is some evidence that exogenous factors may have an impact on hair loss, this is insufficient to support claims that the following are risk factors for the development of androgenetic alopecia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Severi et al, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Gatherwright et al, 2013</a>]:</div><ul><li>Alcohol consumption.</li><li>Markers of androgen activity, such as the timing of the pubertal growth spurt or severity of acne.</li><li>High body mass index.</li><li>Smoking.</li><li>Stress.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Severi et al, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Blume-Peytavi et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Arias-Santiago et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Gatherwright et al, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Dastgheib et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/alopecia-androgenetic-male/references/\">Shamsaldeen et al, 2013</a>]</p><!-- end field 8d3c4884-0dbc-4854-9ec3-27847ddba5d9 --><!-- end item ddc64c67-878a-4009-a6de-d614d05525b3 -->","topic":{"id":"5f58d6a9-7ba5-59ad-b7d6-e461768e2621","topicId":"c4dc3303-ee1d-42aa-8da5-078adb684e06","topicName":"Alopecia, androgenetic - male","slug":"alopecia-androgenetic-male","lastRevised":"Last revised in July 2018","chapters":[{"id":"e3fc5b8b-475e-5a1f-a596-104fbf00064f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c40b9d81-bd18-5ef2-8284-4c4e6005d65c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"d860e13e-49f1-54f2-872f-2f3439f27003","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"bbc072f8-3fd9-5a1c-b94c-a0e4fd6edc2f","slug":"changes","fullItemName":"Changes"},{"id":"746928be-2acf-5ae9-9f81-02a942d56a15","slug":"update","fullItemName":"Update"}]},{"id":"3f6cf011-8136-5f24-8cce-31a439cce866","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5e802365-89ef-5f47-a758-6c880bb456ac","slug":"goals","fullItemName":"Goals"},{"id":"9ed869e3-e3ae-56e1-ae20-0a46d6e20fa2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d90f156b-7429-5580-b4c3-e50d840d1c8a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c879d8ad-590c-56af-9685-9eb9a2e30d54","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9e4f37dc-4cc8-5e88-a803-5ca32ca17da9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5df134be-2105-5321-86a8-71ed6dca8ebb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8a3725c2-b01f-5dd8-a319-33387b40d0ee","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"762358f6-f003-57e8-97ff-1c81299e9364","slug":"definition","fullItemName":"Definition"},{"id":"9ee0c90d-fd96-523f-8f6f-7a26ec56b9c7","slug":"prognosis","fullItemName":"Prognosis"},{"id":"55784b07-7a42-5c0b-9ff3-e9c83216cb1e","slug":"complications","fullItemName":"Complications"},{"id":"7cde82a5-0086-5e04-a669-ec49787685f0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"33fac4d7-a95d-526c-936a-6983e3a12d95","slug":"causes","fullItemName":"Causes"},{"id":"84f86e20-aa91-5e2b-b0b6-bb3cfbf655d6","slug":"risk-factors","fullItemName":"Risk factors"}]},{"id":"4b1bf49e-974e-517b-abd6-59b7ea701502","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"486adc7a-b20b-584e-b20c-1408c8f2dc42","slug":"diagnosis-assessment","fullItemName":"Diagnosis and assessment"},{"id":"afbd97db-7525-51a6-aafe-6e937f1cc3e1","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"4fa73515-d20e-5178-9d6b-eebf5ae2d527","slug":"investigations","fullItemName":"Investigations"}]},{"id":"622bcbbb-d3de-5b15-9b55-ddc4eff327ab","fullItemName":"Management","slug":"management","subChapters":[{"id":"18247780-bdd9-5da4-9d33-1bcf2a883881","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"37e93d68-3a6a-5889-a376-afa236d390aa","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"baab0697-37a1-5edf-88ac-cfb6e2e5656b","slug":"topical-minoxidil-2percent-5percent","fullItemName":"Topical minoxidil 2% and 5%"},{"id":"c42ae7ac-8352-5cac-874c-69c24b99081b","slug":"finasteride","fullItemName":"Finasteride"}]},{"id":"b22c3dba-eb5b-5afa-8f70-43908da7e430","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"444a2a47-2816-5baa-928f-c2bc1b56af85","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1d1c173f-70b1-5d42-916a-a0bcb5c3557c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"531d7be1-4263-5fd6-a49b-a920a3aaca95","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dede1c7c-59ec-550c-be37-91849715881e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ddffa446-a263-56e2-a985-c07fa5d06760","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3b6f4b5d-c7dd-5142-a6e8-2741d9019ade","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0b9ed9ca-1edc-5d61-938a-a6abc5daa77a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8a3725c2-b01f-5dd8-a319-33387b40d0ee","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}